Original Research
Published on 08 Sep 2025
Cost-effectiveness analysis of CDK4/6 inhibitors in the second-line treatment for HR+/HER2− advanced or metastatic breast cancer
in Pharmacology of Anti-Cancer Drugs
- 2,796 views
- 2 citations
Original Research
Published on 08 Sep 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 15 Nov 2024
in Breast Cancer
Original Research
Published on 15 Jan 2025
in Drugs Outcomes Research and Policies
Clinical Trial
Published on 26 Sep 2025
in Drug Metabolism and Transport
Case Report
Published on 13 Apr 2022
in Breast Cancer
Original Research
Published on 18 Jan 2023
in Cancer Molecular Targets and Therapeutics
Systematic Review
Published on 04 Jun 2025
in Breast Cancer
Original Research
Published on 14 Mar 2023
in Breast Cancer
Original Research
Published on 29 Oct 2020
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 02 Jun 2021
in Family Medicine and Primary Care
Original Research
Published on 24 Nov 2020
in Molecular and Cellular Oncology
Case Report
Published on 30 Nov 2022
in Breast Cancer
Original Research
Published on 09 May 2022
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 13 Jun 2023
in Cancer Molecular Targets and Therapeutics
Review
Published on 21 Jun 2019
in Cancer Molecular Targets and Therapeutics
Original Research
Published on 27 Jan 2025
in Breast Cancer